Remove products how-drugs-are-made branded-versus-generics
article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The bill still must pass the Senate, and moreover, how uninsured people with diabetes will deal with steep prices still remains a question. In-house manufacturing the norm.

Insulin 328
article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

Multiple innovative and biosimilar products across our portfolio delivered growth, demonstrating the strength of our business and the depth and breadth of our growth drivers. I remain confident in Pfizer’s ability to continue to deliver on our commitments to our patients and shareholders in 2021 and beyond.”. per share amounts).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Investing In The U.S. Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit

Pharmacy Checkers

Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit”. Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit”. Its mission is to end the crisis of high prescription drug prices in America, and to do so on a bipartisan basis.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

In the meantime, WHO Director-General, Tedros Ghebreyesus feels that “vaccine nationalism” may prove to be the undoing of the potential to halt the spread of COVID-19. FDA commissioner Stephen Hahn himself made a statement echoing Trump that 35 more people out of 100 would survive the coronavirus if treated with the plasma.